Rocket One RKTO
NASDAQ RKTO
$0.67 -0.03 (-4.40%)
At close: Sep 9, 2026 · 4:00 PM EDT

Rocket One (RKTO) Cash & Equivalents (2017 - 2026)

Rocket One's (RKTO) quarterly Cash & Equivalents came in at $7.9 million in Q2 2026, down 12.45% year-over-year from $9.0 million in Q2 2025, and up 95.0% quarter-over-quarter from $4.0 million in Q1 2026.

Analysis

Rocket One (RKTO) Cash & Equivalents (2017 - 2026) Analysis & Trends

Rocket One has disclosed Cash & Equivalents across 10 years of filings, most recently posting $7.9 million for Q2 2026.

  • In Q2 2026, Cash & Equivalents fell 12.45% year-over-year to $7.9 million; the TTM figure through Jun 2026 stood at $7.9 million (down 12.45% YoY), while the FY2025 annual figure was $6.2 million, down 11.24% from the prior year.
  • Cash & Equivalents came in at $7.9 million for Q2 2026 at Rocket One, up from $4.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $13.0 million in Q1 2023 to a low of $4.0 million in Q1 2026.
  • Average Cash & Equivalents over 5 years is $8.7 million, with a median of $8.5 million recorded in 2022.
  • Year-over-year, Cash & Equivalents sank 66.94% in 2022 and soared 104.43% in 2023.
  • Over 5 years, Cash & Equivalents stood at $6.4 million in 2022, then surged by 44.55% to $9.3 million in 2023, then declined by 24.25% to $7.0 million in 2024, then declined by 11.24% to $6.2 million in 2025, then climbed by 26.32% to $7.9 million in 2026.
  • Per Business Quant data, the three most recent Cash & Equivalents figures were $7.9 million in Q2 2026, $4.0 million in Q1 2026, and $6.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 13.99 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 3.18 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 6.14 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 2.46 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 3.58 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 1.72 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.71 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 1.29 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 1.25 Bn
10 Rocket One 13.86 Mn 5.97 Mn - 7.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.89 Mn
Mar 31, 2026 4.05 Mn
Dec 31, 2025 6.25 Mn
Sep 30, 2025 7.85 Mn
Jun 30, 2025 9.01 Mn
Mar 31, 2025 11.32 Mn
Dec 31, 2024 7.04 Mn
Sep 30, 2024 8.02 Mn
Jun 30, 2024 9.65 Mn
Mar 31, 2024 7.60 Mn
Dec 31, 2023 9.29 Mn
Sep 30, 2023 11.83 Mn
Jun 30, 2023 11.54 Mn
Mar 31, 2023 13.04 Mn
Dec 31, 2022 6.43 Mn
Sep 30, 2022 8.94 Mn
Jun 30, 2022 11.32 Mn
Mar 31, 2022 6.38 Mn
Dec 31, 2021 8.54 Mn
Sep 30, 2021 12.45 Mn